GO:0031642

BP

negative regulation of myelination

Any process that stops, prevents, or reduces the frequency, rate or extent of the formation of a myelin sheath around nerve axons.

TNFRSF21, PTEN, MTMR2

GO:0031643

BP

positive regulation of myelination

Any process that activates or increases the frequency, rate or extent of the formation of a myelin sheath around nerve axons.

HGF, MAG, NRG1, TENM4, PARD3, DICER1, MYRF

GO:0031644

BP

regulation of neurological system process

Any process that modulates the frequency, rate or extent of a neurophysiological process, an organ system process carried out by any of the organs or tissues of neurological system.

HTR2C

GO:0031645

BP

negative regulation of neurological system process

Any process that stops, prevents, or reduces the frequency, rate or extent of a neurophysiological process.

NPY2R

GO:0031647

BP

regulation of protein stability

Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation.

AURKA, HDAC3, TADA3, KRAS, APOA2, TF, BCL2, LAMP2, MAPK1, NF2, SREBF1, LSS, NLRP5, CD81, PTEN, CDC42, ANK2, SOX4, PRKD1, CCAR2, RNF149, RNF128, LRRC46, VPS35, USP28, HDAC8, QRSL1, GNL3L, CDKN2AIP, DACT1, TOMM7, DPM3, HDAC6, PYCARD, STUB1, SUGT1, SH3GLB1

GO:0031648

BP

protein destabilization

Any process that decreases the stability of a protein, making it more vulnerable to degradative processes or aggregation.

PARK2, CTSH, BMP2, XBP1, SNCA, ID1, PLK1, PRKDC, MDM2, SIAH1, MYLIP, NCLN, SOX17, BTRC

GO:0031649

BP

heat generation

Any homeostatic process in which an organism produces heat, thereby raising its internal temperature.

ADRB2, ADRB1, ADRB3

GO:0031651

BP

negative regulation of heat generation

Any process that stops, prevents, or reduces the rate or extent of heat generation.

ARRDC3

GO:0031652

BP

positive regulation of heat generation

Any process that activates or increases the rate or extent of heat generation.

ABAT, SLC27A1, APLN

GO:0031658

BP

negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle

Any process that stops, prevents, or reduces the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity contributing to the G1/S transition of the cell cycle.

PTEN

GO:0031659

BP

positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle

Any process that activates or increases the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity contributing to the G1/S transition of the cell cycle.

EGFR, AKT1, ADAM17, PKD1, PKD2, RGCC

GO:0031663

BP

lipopolysaccharide-mediated signaling pathway

A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.

TLR4, IRAK2, RIPK2, TLR2, TGFB1, TNF, IL1B, LYN, CD14, CCL3, CCL2, CCL5, PTAFR, MAPK3, MAPK1, NOS3, CD6, AKT1, IRAK1, IL18, MAPK14, MTDH, SCARB1, PTPN22

GO:0031664

BP

regulation of lipopolysaccharide-mediated signaling pathway

Any process that modulates the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.

CD55

GO:0031665

BP

negative regulation of lipopolysaccharide-mediated signaling pathway

Any process that stops, prevents, or reduces the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.

SIGIRR, TRIB1, NFKBIL1

GO:0031666

BP

positive regulation of lipopolysaccharide-mediated signaling pathway

Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide.

MIF, PRKCA, BMP6

GO:0031667

BP

response to nutrient levels

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.

ACACB, FOXO3, MBD3, CST3, NTRK1, TH, PON1, SRD5A2, FOXO4, SORD, CHSY1, TPH2, PROX1

GO:0031668

BP

cellular response to extracellular stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an extracellular stimulus.

FOS, LYN, FOSL1, ITGA6, ADORA2B, CDKN1A, CDKN2B, SLC1A2, NR4A2, AES

GO:0031669

BP

cellular response to nutrient levels

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.

ULK1, IL6, ICAM1, PRKAA2, TXN2

GO:0031670

BP

cellular response to nutrient

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.

HMOX1, XBP1, CDKN2B

GO:0031848

BP

protection from non-homologous end joining at telomere

A process that prevents non-homologous end joining at telomere, thereby ensuring that telomeres do not fuse.

ACD, DCLRE1C

GO:0031860

BP

telomeric 3' overhang formation

The formation of the single stranded telomeric 3' overhang, a conserved feature that ranges in length from 12 nt in budding yeast to approximately 500 nt in humans.

NBN, MRE11A, RAD50

GO:0031914

BP

negative regulation of synaptic plasticity

A process that decreases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.

CDK5

GO:0031915

BP

positive regulation of synaptic plasticity

A process that increases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.

PTGS2, CDC20, CPLX2

GO:0031929

BP

TOR signaling

A series of molecular signals mediated by TOR (Target of rapamycin) proteins, members of the phosphoinositide (PI) 3-kinase related kinase (PIKK) family that act as serine/threonine kinases in response to nutrient availability or growth factors.

RPS6, EIF4EBP1, EIF4EBP2, CCDC88A, LARP1, RICTOR, FLCN, RHEBL1, FNIP1

GO:0031936

BP

negative regulation of chromatin silencing

Any process that stops, prevents, or reduces the frequency, rate or extent of chromatin silencing.

HMGA1, ATAD2, ASF1A

GO:0031943

BP

regulation of glucocorticoid metabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving glucocorticoids.

GAL, STUB1

GO:0031952

BP

regulation of protein autophosphorylation

Any process that modulates the frequency, rate or extent of addition of the phosphorylation by a protein of one or more of its own residues.

PPP2R5B

GO:0031953

BP

negative regulation of protein autophosphorylation

Any process that stops, prevents or decreases the rate of the phosphorylation by a protein of one or more of its own residues.

JUN, ENPP1, ADIPOQ, CHP1, IMPACT, ERRFI1

GO:0031954

BP

positive regulation of protein autophosphorylation

Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues.

NBN, PDGFB, INS, PDGFA, RAP2A, VEGFA, VEGFC, MRE11A, RAP2B, CALM2, NEK10, RAD50, PDGFD, PDGFC

GO:0031959

BP

mineralocorticoid receptor signaling pathway

Any series of molecular signals generated as a consequence of a mineralocorticoid binding to its receptor.

JAK2, GPER1

GO:0031960

BP

response to corticosteroid

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids.

GNRH1, COL1A1, NOTCH1

GO:0031987

BP

locomotion involved in locomotory behavior

Self-propelled movement of a cell or organism from one location to another in a behavioral context; the aspect of locomotory behavior having to do with movement.

GPR37, ADGRL3, CLN6, FZD4, MYO5A

GO:0031990

BP

mRNA export from nucleus in response to heat stress

The directed movement of mRNA from the nucleus to the cytoplasm during a heat stimulus, a temperature stimulus above the optimal temperature for the organism; in particular, a process that enables an organism withstand exposure to temperatures that would otherwise lethally impair poly(A)+ mRNA-nucleus export.

POLR2D, TPR

GO:0031998

BP

regulation of fatty acid beta-oxidation

Any process that modulates the frequency, rate or extent of fatty acid bbeta-oxidation.

LONP2

GO:0031999

BP

negative regulation of fatty acid beta-oxidation

Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid beta-oxidation.

ACACB, CNR1, AKT1, PLIN5

GO:0032000

BP

positive regulation of fatty acid beta-oxidation

Any process that activates or increases the frequency, rate or extent of fatty acid beta-oxidation.

AKT2, IRS1, CPT1A, PLIN5, PPARA, TWIST1, IRS2

GO:0032006

BP

regulation of TOR signaling

Any process that modulates the frequency, rate or extent of TOR signaling.

GNA12, GPAT3, FLCN, RFFL, FAM83D, RRAGC, FBXO9

GO:0032007

BP

negative regulation of TOR signaling

Any process that stops, prevents, or reduces the frequency, rate or extent of TOR signaling.

ARNTL, PDCD6, EPM2A, TSC2, PRKAA2, NPRL3, MTM1, HIF1A, UBR1, FLCN, DEPTOR, FNIP1, TNFAIP8L1, DDIT4, SH3BP4

GO:0032008

BP

positive regulation of TOR signaling

Any process that activates or increases the frequency, rate or extent of TOR signaling.

HDAC3, LEP, SEC13, GAS6, RHEB, LAMTOR1, RICTOR, SLC38A9, FLCN, SEH1L, MLST8, RRAGC, RRAGD, LAMTOR3, LAMTOR2

GO:0032012

BP

regulation of ARF protein signal transduction

Any process that modulates the frequency, rate or extent of ARF protein signal transduction.

CYTH3, ARFGEF3, IQSEC1, GBF1, FBXO8, PSD3, ARFGEF2

GO:0032020

BP

ISG15-protein conjugation

The covalent addition to a protein of ISG15, a ubiquitin-like protein.

ISG15, UBA7, UBE2E1, UBE2E2

GO:0032024

BP

positive regulation of insulin secretion

Any process that activates or increases the frequency, rate or extent of the regulated release of insulin.

JAK2, PFKFB2, RBP4, GJA1, TRH, ABAT, PPARD, SOX4, TARDBP, NR0B2, PCK2, AACS, SLC30A8, MYRIP, BAD, GPER1, CAPN10, TCF7L2, GHRL, IRS2

GO:0032025

BP

response to cobalt ion

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalt ion stimulus.

ALAD, ATF1, CASP9, CASP8

GO:0032026

BP

response to magnesium ion

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus.

TNFRSF11B, ENTPD6, THBS1, CD14, BMP6, SNCA, MDM2

GO:0032042

BP

mitochondrial DNA metabolic process

The chemical reactions and pathways involving mitochondrial DNA.

PARP1, SESN2

GO:0032049

BP

cardiolipin biosynthetic process

The chemical reactions and pathways resulting in the formation of cardiolipin, 1,3-bis(3-phosphatidyl)glycerol.

PGS1, SLC27A1, PTPMT1, CRLS1

GO:0032053

BP

ciliary basal body organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a ciliary basal body, a short cylindrical array of microtubules and associated proteins found at the base of a eukaryotic cilium (also called flagellum).

CROCC

GO:0032055

BP

negative regulation of translation in response to stress

Any process that stops, prevents or reduces the rate of translation as a result of a stimulus indicating the organism is under stress.

RBM4

GO:0032057

BP

negative regulation of translational initiation in response to stress

Any process that stops, prevents or reduces the rate of translation initiation as a result of a stimulus indicating the organism is under stress.

EIF2S1, ATF4, EIF2B5, EIF2B3, EIF2AK4, EIF2B4

GO:0032058

BP

positive regulation of translational initiation in response to stress

Any process that activates or increases the frequency, rate or extent of translation initiation as a result of a stimulus indicating the organism is under stress.

PPP1R15A

GO:0032060

BP

bleb assembly

The assembly of a bleb, a cell extension caused by localized decoupling of the cytoskeleton from the plasma membrane and characterized by rapid formation, rounded shape, and scarcity of organelles within the protrusion. Plasma membrane blebbing occurs during apoptosis and other cellular processes, including cell locomotion, cell division, and as a result of physical or chemical stresses.

EMP1, EMP2, EMP3, PMP22, MYLK, ANO6

GO:0032066

BP

nucleolus to nucleoplasm transport

The directed movement of substances from the nucleolus to the nucleoplasm.

TBRG1, NOC2L

GO:0032071

BP

regulation of endodeoxyribonuclease activity

Any process that modulates the frequency, rate or extent of endodeoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid by creating internal breaks.

NPM1

GO:0032072

BP

regulation of restriction endodeoxyribonuclease activity

Any process that modulates the frequency, rate or extent of a restriction endodeoxyribonuclease activity, the catalysis of endonucleolytic cleavage of DNA in a site-specific manner, resulting in double-strand breaks.

HMGB1

GO:0032075

BP

positive regulation of nuclease activity

Any process that activates or increases the frequency, rate or extent of nuclease activity, the hydrolysis of ester linkages within nucleic acids.

HMGB2

GO:0032077

BP

positive regulation of deoxyribonuclease activity

Any process that activates or increases the frequency, rate or extent of deoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid.

PCNA

GO:0032079

BP

positive regulation of endodeoxyribonuclease activity

Any process that activates or increases the frequency, rate or extent of endodeoxyribonuclease activity, the hydrolysis of ester linkages within deoxyribonucleic acid by creating internal breaks.

AKT1, PRKCD

GO:0032088

BP

negative regulation of NF-kappaB transcription factor activity

Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB.

IRAK2, KLF4, PSMD10, TRIM37, ANXA4, TNFAIP3, DAP, IRAK1, MAP2K5, PTGIS, CYP1B1, COMMD6, TAX1BP1, NLRC5, COMMD1, SETD6, ZNF675, PELI1, ITCH, NR1H4, CHP1, FOXP3, CYLD, NFKBIL1, PYCARD, IRAK3

GO:0032091

BP

negative regulation of protein binding

Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.

ITGB1BP1, AURKA, KDM1A, PEX14, DKK1, PDGFB, SLPI, RALB, ACE, LRPAP1, MAPK8, NES, CSNK1E, GSK3B, PPP1CA, DAB2, CAV1, PRKCD, BAX, PPARA, AES, GOLGA2, TDG, CAMK1, NFATC4, CARM1, TEX14, MITD1, SORL1, AURKB, GNL3L, DACT1, STUB1

GO:0032092

BP

positive regulation of protein binding

Any process that activates or increases the frequency, rate or extent of protein binding.

KRIT1, FLOT1, GCG, VTN, HSP90AB1, RALB, BMP2, BMP4, ACE, WNT5A, GSK3B, B2M, PKD1, CDK5, CAV1, EP300, TIAM1, STK4, BAMBI, ARHGEF7, HFE, SPPL3, CTHRC1, TRIB3, HIPK2, AKTIP, TCF7L2, DACT1, PLK2, AMFR, PLXND1

GO:0032094

BP

response to food

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat.

BCL10, GHRH, CYP1A1, MPO, G6PD, AKT1, G6PC, CHRNA7, SREBF1, HSD11B2, GHSR

GO:0032095

BP

regulation of response to food

Any process that modulates the frequency, rate or extent of a response to a food stimulus.

MT3, GHRL

GO:0032098

BP

regulation of appetite

Any process which modulates appetite, the desire or physical craving for food.

SLC22A3, POMC, HTR2C

GO:0032099

BP

negative regulation of appetite

Any process that reduces appetite.

CCK, LEP, PPARA, CARTPT, SPX, NENF

GO:0032100

BP

positive regulation of appetite

Any process that increases appetite.

GHSR, GHRL

GO:0032119

BP

sequestering of zinc ion

The process of binding or confining zinc ions such that they are separated from other components of a biological system.

S100A8, S100A9, SLC30A8

GO:0032147

BP

activation of protein kinase activity

Any process that initiates the activity of an inactive protein kinase.

AXIN1, PDGFB, ITGB3, RPLP1, INSR, DRD2, VEGFA, TGFBR2, PIK3CA, SLC11A1, EMP2, TGFB2, PRKCD, DLG1, ACVR2B, KIF14, STK11, DBF4B, DUSP19, FGF13, STRADB, WNK1, RGCC, ECT2, GPRC5B, TPX2, CAB39

GO:0032148

BP

activation of protein kinase B activity

Any process that initiates the activity of the inactive enzyme protein kinase B.

ITGB1BP1, PDGFB, INS, ANG, IGF1, INSR, TXN, ADRA2B, MT3, WNT5A, NRG1, IL18, GAS6, CCDC88A, PINK1, OSBPL8

GO:0032200

BP

telomere organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of telomeres, terminal regions of a linear chromosome that include the telomeric DNA repeats and associated proteins.

HIST1H4A, HIST1H3D, H3F3A

GO:0032202

BP

telomere assembly

A cellular process that results in the aggregation, arrangement and bonding together of a set of components to form a telomere at a non-telomeric double-stranded DNA end. A telomere is a terminal region of a linear chromosome that includes telomeric DNA repeats and associated proteins.

ACD, POT1

GO:0032204

BP

regulation of telomere maintenance

Any process that modulates the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA.

MYC, HDAC8, PIF1, SMG5

GO:0032205

BP

negative regulation of telomere maintenance

Any process that stops, prevents, or reduces the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA.

ERCC1, ERCC4

GO:0032206

BP

positive regulation of telomere maintenance

Any process that activates or increases the frequency, rate or extent of a process that affects and monitors the activity of telomeric proteins and the length of telomeric DNA.

NBN, ATRX, MRE11A, RAD50, GNL3, DHX36

GO:0032210

BP

regulation of telomere maintenance via telomerase

Any process that modulates the frequency, rate or extent of the addition of telomeric repeats by telomerase.

TNKS, SMG5

GO:0032211

BP

negative regulation of telomere maintenance via telomerase

Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of telomeric repeats by telomerase.

HNRNPC, HNRNPA1, TERF1, HNRNPU, ACD, PIF1, GNL3L

GO:0032212

BP

positive regulation of telomere maintenance via telomerase

Any process that activates or increases the frequency, rate or extent of the addition of telomeric repeats by telomerase.

MAP2K7, DKC1, TNKS, HNRNPA1, TCP1, MAPK3, MAPK1, CTNNB1, CCT6A, CCT3, CCT8, NEK2, CCT2, PRKCQ, NEK7, ACD, AURKB, CCT7, TNKS2, OBFC1, POT1, MAP3K4

GO:0032214

BP

negative regulation of telomere maintenance via semi-conservative replication

Any process that stops, prevents, or reduces the frequency, rate or extent of the semi-conservative replication of telomeric DNA.

TERF1

GO:0032218

BP

riboflavin transport

The directed movement of riboflavin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Riboflavin (vitamin B2) is a water-soluble B-complex vitamin, converted in the cell to FMN and FAD, cofactors required for the function of flavoproteins.

SLC52A3

GO:0032224

BP

positive regulation of synaptic transmission, cholinergic

Any process that activates, maintains or increases the frequency, rate or extent of cholinergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter acetylcholine.

LAMA2

GO:0032225

BP

regulation of synaptic transmission, dopaminergic

Any process that modulates the frequency, rate or extent of dopaminergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter dopamine.

CHRNA7, PNKD

GO:0032226

BP

positive regulation of synaptic transmission, dopaminergic

Any process that activates, maintains or increases the frequency, rate or extent of dopaminergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter dopamine.

FLOT1, PINK1

GO:0032227

BP

negative regulation of synaptic transmission, dopaminergic

Any process that stops, prevents, or reduces the frequency, rate or extent of dopaminergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter dopamine.

PTGS2

GO:0032228

BP

regulation of synaptic transmission, GABAergic

Any process that modulates the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA).

KRAS, DRD2, CNR1, PTEN, USP46, PLCL1, PLCL2, NISCH

GO:0032229

BP

negative regulation of synaptic transmission, GABAergic

Any process that stops, prevents, or reduces the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA).

SLC6A1, ADORA1, STXBP1, NPY5R

GO:0032230

BP

positive regulation of synaptic transmission, GABAergic

Any process that activates, maintains or increases the frequency, rate or extent of GABAergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter gamma-aminobutyric acid (GABA).

CA2, OXTR, ADRA1A, NLGN1

GO:0032231

BP

regulation of actin filament bundle assembly

Any process that modulates the frequency, rate or extent of the assembly of actin filament bundles.

RDX

GO:0032232

BP

negative regulation of actin filament bundle assembly

Any process that stops, prevents, or reduces the frequency, rate or extent of the assembly of actin filament bundles.

PARK2, PFN1

GO:0032233

BP

positive regulation of actin filament bundle assembly

Any process that activates or increases the frequency, rate or extent of the assembly of actin filament bundles.

PFN1, ID1, SYNPO2

GO:0032237

BP

activation of store-operated calcium channel activity

A process that initiates the activity of an inactive store-operated calcium channel.

PLCG2, STIM2

GO:0032244

BP

positive regulation of nucleoside transport

Any process that activates or increases the frequency, rate or extent of the directed movement of a nucleoside into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

ADORA1

GO:0032252

BP

secretory granule localization

Any process in which a secretory granule is transported to, and/or maintained in, a specific location within the cell.

PIK3CG, MYO5A

GO:0032259

BP

methylation

The process in which a methyl group is covalently attached to a molecule.

TYMS, PNMT, COMT, GCSH, AHCY, MAT2A, NNMT, HNMT, TPMT, PRDM15, GSTO1, MTAP, NDUFAF5, TYW3, METTL23, SETD9, MTR, DPH5, METTL17, METTL8, METTL7A, AS3MT, PRDM10, METTL5, FAM86C1, COQ3, MAT2B, PEMT, N6AMT1

GO:0032261

BP

purine nucleotide salvage

Any process which produces a purine nucleotide from derivatives of it, without de novo synthesis.

ADA

GO:0032264

BP

IMP salvage

Any process which produces inosine monophosphate from derivatives of it, without de novo synthesis.

AMPD3

GO:0032268

BP

regulation of cellular protein metabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.

PM20D2

GO:0032269

BP

negative regulation of cellular protein metabolic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.

EDN1, MIF, NFKB1

GO:0032270

BP

positive regulation of cellular protein metabolic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.

KLF4, AGT, TGFB1, INS, INHBA, AGTR1, AKT1, NR1H2, NR1H3, ADIPOQ, UHRF1

GO:0032272

BP

negative regulation of protein polymerization

Any process that stops, prevents, or reduces the frequency, rate or extent of the process of creating protein polymers.

VDAC2

GO:0032273

BP

positive regulation of protein polymerization

Any process that activates or increases the frequency, rate or extent of the process of creating protein polymers.

TPPP

GO:0032275

BP

luteinizing hormone secretion

The regulated release of luteinizing hormone, a gonadotropic glycoprotein hormone secreted by the anterior pituitary.

TMF1